Natalizumab, B cells and MS
Posted: Tue Mar 29, 2016 11:14 pm
Hi everyone,
We have posted a new research summary on our website. This is an easy to understand piece regarding a new paper that has been published, which looks at how certain cells of the immune system may be influenced by treatment with natalizumab (Tysabri). They have shown that these cells, called regulatory B cells, don't work as well under these conditions. This is important as it gives a potentially new target for more effective therapies and may also help provide some insight into how to prevent PML (a major potential risk associated with the use of Tysabri and other MS therapies).
You can read the full summary via the link below and I'm happy to answer any questions:
http://www.mstranslate.com.au/natalizum ... sclerosis/
Thanks,
Brett (MS researcher, science communicator and co-founder of MStranslate)
We have posted a new research summary on our website. This is an easy to understand piece regarding a new paper that has been published, which looks at how certain cells of the immune system may be influenced by treatment with natalizumab (Tysabri). They have shown that these cells, called regulatory B cells, don't work as well under these conditions. This is important as it gives a potentially new target for more effective therapies and may also help provide some insight into how to prevent PML (a major potential risk associated with the use of Tysabri and other MS therapies).
You can read the full summary via the link below and I'm happy to answer any questions:
http://www.mstranslate.com.au/natalizum ... sclerosis/
Thanks,
Brett (MS researcher, science communicator and co-founder of MStranslate)